Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us ...
GSK has selected a liver disease drug candidate from its collaboration with Wave Life Sciences for further development, ...
Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, ...
Swedish biotech Atrogi says its oral drug ATR-258 increased lower-extremity muscle power by about 13% after eight weeks in a ...
Boehringer Ingelheim’s survodutide delivered average weight loss of up to 13.1% in a Phase 3 trial involving people with ...
Kos Biotechnology Partners has raised US$123m (€106m) for its inaugural global life sciences fund, marking a notable step for Greece’s still young biotechnology financing ecosystem. The New York- and ...
In proceedings before the European Patent Office (EPO), applicants are required to „adapt“ the description to the claims of a ...
Qure’s shares fell about 40% in early trading on September 29 after its Huntington’s gene therapy missed statistical ...
Swedish biotech AnaCardio has raised €62.5 million to take its oral heart failure drug AC01 through Phase 2b, testing whether ...
Sweden’s Nanexa has granted Novo Nordisk a global license to use its PharmaShell drug delivery technology in up to five ...
The 2025 AseBio Report shows a Spanish biotech ecosystem that is not only expanding, but attracting capital at a new scale: ...
Newron Pharmaceuticals will expand its Phase 3 evenamide trial outside the U.S. after the FDA decided to maintain a hold on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results